[1] Mitoma H, Mizusawa H. Autoantibodies to GAD and autoimmune-mediated neurological diseases[J]. Nihon Rinsho, 2013, 71:921-926. [2] Ständer SHD, Reboul CF, Le SN, Williams DE, Chandler PG, Costa MGS, Hoke DE, Jimma JDT, Fodor J, Fenalti G, Mannering SI, Porebski BT, Schofield P, Christ D, Buckle M, McGowan S, Elmlund D, Rand KD, Buckle AM. Structure and dynamics of GAD65 in complex with an autoimmune polyendocrine syndrome type 2-associated autoantibody[J]. Nat Commun, 2025, 16:2275. [3] Fan X, Li X, Wang S, Zhu Y, Liu S, Han X. Clinical heterogeneity in acute symptomatic seizures due to autoimmune encephalitis related to GAD65 antibodies[J]. Neuroimmunomodulation, 2022, 29:171-176. [4] Zhu F, Shan W, Lv R, Li Z, Wang Q. Clinical characteristics of GAD 65-associated autoimmune encephalitis[J]. Acta Neurol Scand, 2020, 142:281-293. [5] Harmon A, Stingl C, Rikhi A, Tran L, Pizoli C, Malinzak M, Van Mater H. Pediatric GAD-65 autoimmune encephalitis:assessing clinical characteristics and response to therapy with a novel assessment scale[J]. Pediatr Neurol, 2022, 128:25-32. [6] Li G, Liu X, Yu T, Ren J, Wang Q. Positron emission tomography in autoimmune encephalitis:clinical implications and future directions[J]. Acta Neurol Scand, 2022, 146:708-715. [7] Yin Y, Wu J, Wu S, Chen S, Cheng W, Li L, Wang H. Usefulness of brain FDG PET/CT imaging in pediatric patients with suspected autoimmune encephalitis from a prospective study[J]. Eur J Nucl Med Mol Imaging, 2022, 49:1918-1929. [8] Kalra S, Tripathi M, Tripathi M, Sonar RS, Pandey AK, Jaleel J, Singh RK, Kumar P, Damle NA, Bal C. Role of FDG PET/CT in definitive and presumed autoimmune encephalitis[J]. Nucl Med Commun, 2024, 45:121-127. [9] Bordonne M, Chawki MB, Doyen M, Kas A, Guedj E, Tyvaert L, Verger A. Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis:a systematic review and a meta-analysis[J]. Eur J Nucl Med Mol Imaging, 2021, 48:3847-3858. [10] Bergeret S, Birzu C, Meneret P, Giron A, Demeret S, Marois C, Cousyn L, Rozenblum L, Laurenge A, Alentorn A, Navarro V, Psimaras D, Kas A. Brain metabolic alterations in seropositive autoimmune encephalitis:an 18F-FDG PET study[J]. Biomedicines, 2023, 11:506. [11] Sun Y, Sun R, Lv J, Kong Q, Dai C, Wang B, Han X, Chen M, Liu R, Jiang Y, Yuan L, Ai L, Yang X, Chen Y, Wang Q. Diagnosis and subtyping of autoimmune encephalitis using an attention-based multi-instance learning model:a multi-center 18F-FDG PET study[J]. CNS Neurosci Ther, 2025, 31:e70513. [12] Deuschl C, Rüber T, Ernst L, Fendler WP, Kirchner J, Mönninghoff C, Herrmann K, Quesada CM, Forsting M, Elger CE, Umutlu L. 18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis[J]. PLoS One, 2020, 15:e0227906. [13] Tripathi M, Tripathi M, Roy SG, Parida GK, Ihtisham K, Dash D, Damle N, Shamim SA, Bal C. Metabolic topography of autoimmune non-paraneoplastic encephalitis[J]. Neuroradiology, 2018, 60:189-198. [14] Baumgartner A, Rauer S, Mader I, Meyer PT. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis:correlation with autoantibody types[J]. J Neurol, 2013, 260:2744-2753. [15] Sun Y, Li G, Liu X, Zhao X, Ren J, Ren G, Liu Y, Ai L, Wang Q. Cerebral glucose hypometabolism and hypoperfusion of cingulate gyrus:an imaging biomarker of autoimmune encephalitis with psychiatric symptoms[J]. J Neurol, 2024, 271:1247-1255. Lu Q, Lin N, Liu M, Fan S, Cui R, [16] Bai L, Ren H, Liang M, Guan H. Neurological disorders associated with glutamic acid decarboxylase 65 antibodies:clinical spectrum and prognosis of a cohort from China[J]. Front Neurol, 2022, 13:990553. [17] Nabizadeh F, Ramezannezhad E, Sardaripour A, Seyedi SA, Salehi N, Rezaeimanesh N, Naser Moghadasi A.[18F]FDG brain PET and clinical symptoms in different autoantibodies of autoimmune encephalitis:a systematic review[J]. Neurol Sci, 2022, 43:4701-4718. [18] Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol, 2016, 15:391-404. [19] Chinese Society of Neuroinfectious Diseases and Cerebrospinal Fluid Cytology. Chinese expert consensus on the diagnosis and management of autoimmune encephalitis (2022 edition)[J]. Zhonghua Shen Jing Ke Za Zhi, 2022, 55:931-949.[中华医学会神经病学分会神经感染性疾病与脑脊液细胞学学组.中国自身免疫性脑炎诊治专家共识(2022年版)[J].中华神经科杂志, 2022, 55:931-949.] [20] Destrieux C, Fischl B, Dale A, Halgren E. Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature[J]. Neuroimage, 2010, 53:1-15. [21] Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain[J]. Neuroimage, 2002, 15:273-289. [22] Kuang Z, Baizabal-Carvallo JF, Alonso-Juarez M, Mofatteh M, Rissardo JP, Pan M, Ye J, Wang Z, Chen Y. The limbic and extra-limbic encephalitis associated with glutamic acid decarboxylase (GAD)-65 antibodies:an observational study[J]. Neurol Sci, 2025, 46:2765-2777.[23] Parlar YE, Ayar SN, Cagdas D, Balaban YH. Liver immunity, autoimmunity, and inborn errors of immunity[J]. World J Hepatol, 2023, 15:52-67. [24] Grilo E, Pinto J, Caetano JS, Pereira H, Cardoso P, Cardoso R, Dinis I, Pereira C, Fineza I, Mirante A. Type 1 diabetes and GAD65 limbic encephalitis:a case report of a 10-year-old girl[J]. J Pediatr Endocrinol Metab, 2016, 29:985-990. [25] Dade M, Giry M, Berzero G, Benazra M, Huberfeld G, Leclercq D, Navarro V, Delattre JY, Psimaras D, Alentorn A. Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies[J]. Neuroimage Clin, 2021, 32:102826. [26] Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, Brendel M, Cecchin D, Ekmekcioglu O, Garibotto V, Lammertsma AA, Law I, Peñuelas I, Semah F, Traub-Weidinger T, van de Giessen E, Van Weehaeghe D, Morbelli S. EANM procedure guidelines for brain PET imaging using[18F]FDG, version 3[J]. Eur J Nucl Med Mol Imaging, 2022, 49:632-651. [27] Taneja S, Suri V, Ahuja A, Jena A. Simultaneous 18F-FDG PET/MRI in autoimmune limbic encephalitis[J]. Indian J Nucl Med, 2018, 33:174-176. [28] Bauer T, Ernst L, David B, Becker AJ, Wagner J, Witt JA, Helmstaedter C, Weber B, Hattingen E, Elger CE, Surges R, Rüber T. Fixel-based analysis links white matter characteristics, serostatus and clinical features in limbic encephalitis[J]. Neuroimage Clin, 2020, 27:102289. S, Sala-Padró J, Miro J, [29] Falip M, Rodriguez-Bel L, Castañer Jaraba S, Casasnovas C, Morandeira F, Berdejo J, Carreño M. Hippocampus and insula are targets in epileptic patients with glutamic acid decarboxylase antibodies[J]. Front Neurol, 2019, 9:1143. [30] Fattahzadeh Ardalani G, Samady Khanghah A, Jahanpanah M, Mokhtari D, Samady Khanghah P. Successfully treated anti-GAD limbic encephalitis in a 15-year-old diabetic boy with intravenous immunoglobulin:case report[J]. Ann Med Surg (Lond), 2024, 86:1173-1181. [31] Meinecke DL, Rakic P. Expression of GABA and GABAA receptors by neurons of the subplate zone in developing primate occipital cortex:evidence for transient local circuits[J]. J Comp Neurol, 1992, 317:91-101. [32] Broadley J, Wesselingh R, Seneviratne U, Kyndt C, Beech P, Buzzard K, Nesbitt C, D'souza W, Brodtmann A, Macdonell R, Kalincik T, Butzkueven H, O'Brien TJ, Monif M; Australian Autoimmune Encephalitis Consortium. Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis[J]. J Neuroimmunol, 2021, 353:577508. [33] Shen S, Wei R, Gao Y, Yang X, Zhang G, Yan B, Xiao Z, Li J. Cortical atrophy in early-stage patients with anti-NMDA receptor encephalitis:a machine-learning MRI study with various feature extraction[J]. Cereb Cortex, 2024, 34:bhad499. [34] Wu HT, Huang SS, Liu XY, Zhu SQ. Analysis of clinical characteristics of antiglutamic acid decarboxylase 65 antibody-positive autoimmune-associated epilepsy[J]. Zhonghua Shen Jing Ke Za Zhi, 2024, 57:959-967.[吴辉婷,黄珊珊,刘晓艳,朱遂强.抗谷氨酸脱羧酶65抗体阳性的自身免疫相关性癫痫的临床特征分析[J].中华神经科杂志, 2024, 57:959-967.] |